JAK2 and leukemia: Hence, the mouse Pax5Jak2/+ model appears to generate, through loss of the wild‐type Pax5 allele, a more aggressive leukemia and thus does not recapitulate all aspects of the human PAX5‐JAK2+ B‐ALL disease.